Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Cell-mediated Immunity and Antibody Response to Influenza Vaccination and Correlates of Protection in Seniors

NCT01189123 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT01189123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01189123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Cell-mediated Immunity and Antibody Response to Influenza Vaccination and Correlates of Protection in Seniors
Lead sponsor
Vanderbilt University
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2010
Completion date
August 31, 2013
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunity to influenza vaccine